COMMUNIQUÉ DE PRESSE publié le 08/07/2024 à 16:30, il y a 4 mois 14 jours Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs) New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025 Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease
Publié le 22/11/2024 à 16:15, il y a 16 heures 49 minutes NRJ GROUP - Le Conseil d'Etat rejette le recours de NRJ 12 et NRJ GROUP
Publié le 21/11/2024 à 06:58, il y a 2 jours 2 heures Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 22/11/2024 à 23:55, il y a 9 heures 10 minutes Boron One Announces Early Warrant Exercise Incentive Program
Publié le 22/11/2024 à 23:30, il y a 9 heures 35 minutes Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Publié le 22/11/2024 à 23:05, il y a 10 heures Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Publié le 22/11/2024 à 22:30, il y a 10 heures 35 minutes Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Publié le 22/11/2024 à 18:14, il y a 14 heures 50 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/11/2024 à 17:53, il y a 15 heures 11 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 22/11/2024 à 16:55, il y a 16 heures 9 minutes EQS-Adhoc: Comment on withdrawn non-binding offer
Publié le 22/11/2024 à 16:00, il y a 17 heures 5 minutes Proposed cancellation of admission to trading
